A Randomized, Controlled Trial to Compare Protection in Adolescents Between Different Meningococcal Immunization Schedules Used in Canada; a Canadian Immunization Research Network (CIRN) Study
Phase of Trial: Phase IV
Latest Information Update: 24 Jul 2019
Price : $35 *
At a glance
- Drugs Meningococcal vaccine groups A C Y W-135 conjugate (Primary)
- Indications Meningococcal infections
- Focus Therapeutic Use
- 19 Jul 2019 Planned End Date changed from 1 Mar 2020 to 1 Mar 2021.
- 19 Jul 2019 Planned primary completion date changed from 1 Dec 2019 to 1 Dec 2020.
- 10 Oct 2018 New trial record